These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 20705309

  • 1. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
    Reaiche GY, Le Mire MF, Mason WS, Jilbert AR.
    Virology; 2010 Oct 25; 406(2):286-92. PubMed ID: 20705309
    [Abstract] [Full Text] [Related]

  • 2. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
    Le Mire MF, Miller DS, Foster WK, Burrell CJ, Jilbert AR.
    J Virol; 2005 Oct 25; 79(19):12242-52. PubMed ID: 16160150
    [Abstract] [Full Text] [Related]

  • 3. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS, Boyle D, Feng F, Reaiche GY, Kotlarski I, Colonno R, Jilbert AR.
    Virology; 2008 Apr 10; 373(2):329-41. PubMed ID: 18206204
    [Abstract] [Full Text] [Related]

  • 4. [Inhibitory effect of trisodium phosphonoformate (PFA) on duck hepatitis B virus (DHBV) DNA in vivo].
    Chen X, Chen H.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 10; 11(3):277-81. PubMed ID: 15617348
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo].
    Chen G, Chen J, Liu D, Zhang X, Zhu C, Li Y, Wang L, Yang Y, Cai G, Han F.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec 10; 11(4):329-32. PubMed ID: 15617240
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
    Lenhoff RJ, Luscombe CA, Summers J.
    Hepatology; 1999 Feb 10; 29(2):563-71. PubMed ID: 9918936
    [Abstract] [Full Text] [Related]

  • 12. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
    Foster WK, Miller DS, Scougall CA, Kotlarski I, Colonno RJ, Jilbert AR.
    J Virol; 2005 May 10; 79(9):5819-32. PubMed ID: 15827196
    [Abstract] [Full Text] [Related]

  • 13. Isolation and identification of an anti-hepatitis B virus compound from Hydrocotyle sibthorpioides Lam.
    Huang Q, Zhang S, Huang R, Wei L, Chen Y, Lv S, Liang C, Tan S, Liang S, Zhuo L, Lin X.
    J Ethnopharmacol; 2013 Nov 25; 150(2):568-75. PubMed ID: 24051027
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
    Jilbert AR, Miller DS, Scougall CA, Turnbull H, Burrell CJ.
    Virology; 1996 Dec 15; 226(2):338-45. PubMed ID: 8955053
    [Abstract] [Full Text] [Related]

  • 15. In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.
    Saade F, Buronfosse T, Guerret S, Pradat P, Chevallier M, Zoulim F, Jamard C, Cova L.
    J Viral Hepat; 2013 Apr 15; 20(4):e56-65. PubMed ID: 23490390
    [Abstract] [Full Text] [Related]

  • 16. Viral load in 1-day-old ducklings acutely infected with duck hepatitis B virus by different doses and routes of inoculation.
    Chen ZY, Cheng AC, Wang MS, Xu DW, Jia R, Guo YF, Zeng W.
    Avian Pathol; 2009 Apr 15; 38(2):129-34. PubMed ID: 19322711
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
    Mason WS, Cullen J, Saputelli J, Wu TT, Liu C, London WT, Lustbader E, Schaffer P, O'Connell AP, Fourel I.
    Hepatology; 1994 Feb 15; 19(2):398-411. PubMed ID: 8294097
    [Abstract] [Full Text] [Related]

  • 18. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.
    Luscombe C, Pedersen J, Uren E, Locarnini S.
    Hepatology; 1996 Oct 15; 24(4):766-73. PubMed ID: 8855174
    [Abstract] [Full Text] [Related]

  • 19. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
    Sauerbrei A, Schacke M, Schultz U, Egerer R, Merkle I, Glebe D, Gerlich W, Wutzler P.
    J Virol Methods; 2005 Nov 15; 129(2):178-85. PubMed ID: 16002155
    [Abstract] [Full Text] [Related]

  • 20. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
    Schorr O, Borel C, Trepo C, Zoulim F, Hantz O.
    J Hepatol; 2006 May 15; 44(5):842-7. PubMed ID: 16458387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.